Literature DB >> 11309066

Activation of clindamycin phosphate by human skin.

S Amr1, M B Brown, G P Martin, B Forbes.   

Abstract

AIMS: To investigate the relative antimicrobial activity of clindamycin phosphate (CP) and clindamycin (Cly) and to examine the effect of skin homogenates on the activity of CP. METHODS AND
RESULTS: Minimum inhibitory concentrations (MIC) were determined against dermally relevant organisms and bactericidal activity was studied using time-kill methodology. The effect of skin homogenates on the antimicrobial activity of CP was studied by well-diffusion assay. The MIC of Cly was substantially lower than that of CP in all susceptible organisms. Clindamycin also showed greater bactericidal activity (rate of kill) than CP. Phosphatases in skin homogenates activated CP at pH 4-8 with a maximal activation at pH 4.
CONCLUSION: Phosphatases within the skin have been shown to convert CP to the more potent form Cly. SIGNIFICANCE AND IMPACT OF THE STUDY: Conversion to Cly is a major determinant of antimicrobial activity in the skin layers following topical application of CP.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309066     DOI: 10.1046/j.1365-2672.2001.01282.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  3 in total

1.  Tracking the dephosphorylation of resveratrol triphosphate in skin by confocal Raman microscopy.

Authors:  Guojin Zhang; Carol R Flach; Richard Mendelsohn
Journal:  J Control Release       Date:  2007-08-15       Impact factor: 9.776

2.  Rapid identification of magnesium ascorbyl phosphate utilizing phosphatase through a chromogenic change-coupled activity assay.

Authors:  Yuli Wang; Wenyue Hu; Zixin Deng; Xinyi He
Journal:  Appl Microbiol Biotechnol       Date:  2021-03-22       Impact factor: 4.813

3.  Injectable Platelet-Rich Fibrin as a Drug Carrier Increases the Antibacterial Susceptibility of Antibiotic-Clindamycin Phosphate.

Authors:  Karina Egle; Ingus Skadins; Andra Grava; Lana Micko; Viktors Dubniks; Ilze Salma; Arita Dubnika
Journal:  Int J Mol Sci       Date:  2022-07-03       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.